SHELAGH LARSON: Open Payments
NPI 1215077219 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,303 in 21 payments from 11 companies in 2025. Trend: 2023 $15,548 · 2024 $2,809 · 2025 $9,303
Speaker / faculty: $4,180Speaker / faculty: $2,009Consulting: $1,784Food & beverage: $1,330
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 7 | $4,225 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $3,903 |
| Sumitomo Pharma America, Inc. | 3 | $220 |
| Corcept Therapeutics | 1 | $127 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $126 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $121 |
| Lilly USA, LLC | 1 | $119 |
| SANOFI-AVENTIS U.S. LLC | 1 | $119 |
| Novo Nordisk Inc | 1 | $111 |
Products named: NEXPLANON, Lynkuet, GEMTESA, Korlym, NEFFY, REXULTI, GATTEX, MOUNJARO.
Industry payments across TX — which companies pay providers there.
